Description

Dinar (ethylmethylhydroxypyridine succinate) solution for injections 50 mg/ml. 2 ml. ampoules №10

Ingredients:

Each 2 ml ampoule contains 100 mg of ethylmethylhydroxypyridine succinate as the active ingredient.

Dosage:

The recommended dosage is determined by a healthcare professional and administered via intramuscular or intravenous injection.

Indications:

Dinar solution is indicated for the treatment of cerebrovascular disorders, cognitive impairment, and neurological conditions associated with cerebral circulation insufficiency.

Contraindications:

Do not use Dinar solution in patients with hypersensitivity to the active ingredient or any of the excipients.

Directions:

Administer the solution as directed by a healthcare provider. Do not exceed the recommended dosage or frequency of administration.

Scientific Evidence:

Dinar (ethylmethylhydroxypyridine succinate) has shown promising results in improving cognitive function and neurological outcomes in patients with cerebrovascular disorders.

Studies have demonstrated the neuroprotective and antioxidant properties of ethylmethylhydroxypyridine succinate, highlighting its potential in the management of cerebral circulation insufficiency.

Additional Information:

It is important to monitor patients closely for any adverse reactions or side effects during treatment with Dinar solution.

Consult a healthcare professional for more information on the use of Dinar solution and its potential benefits in the management of cerebrovascular disorders.